Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A17878 | 27506737 | Metabolism | Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review. | 2016 | Details |
| A17880 | 27501771 | Br J Nutr | Differences in metabolic biomarkers in the blood and gene expression profiles of peripheral blood mononuclear cells among normal weight, mildly obese and moderately obese subjects. | 2016 | Details |
| A17881 | 27501738 | J Hepatol | Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease. | 2016 | Details |
| A17889 | 27494683 | Int Immunopharmacol | High-fat diet plus carbon tetrachloride-induced liver fibrosis is alleviated by betaine treatment in rats. | 2016 | Details |
| A17892 | 27493111 | Ann Hepatol |  High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients. | 2017 | Details |
| A17895 | 27493105 | Ann Hepatol |  NASH: A glance at the landscape of pharmacological treatment. | 2017 | Details |
| A17898 | 27492250 | Hepatol Res | Role of thrombospondin 1 in liver diseases. | 2016 | Details |
| A17900 | 27488610 | Eur J Nutr | The in vivo antineoplastic and therapeutic efficacy of troxerutin on rat preneoplastic liver: biochemical, histological and cellular aspects. | 2016 | Details |
| A17901 | 27487733 | Food Funct | Protective effects of glycyrrhizic acid from edible botanical glycyrrhiza glabra against non-alcoholic steatohepatitis in mice. | 2016 | Details |
| A17904 | 27485838 | Curr HIV/AIDS Rep | Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV. | 2016 | Details |
| A17905 | 27485440 | Nutr J | Role of bioactive fatty acids in nonalcoholic fatty liver disease. | 2016 | Details |
| A17931 | 27470627 | Zhonghua Gan Zang Bing Za Zhi | [Establishment and evaluation of a mouse model of nonalcoholic steatohepatitis-related hepatocellular carcinoma]. | 2016 | Details |
| A17943 | 27462372 | Diabetol Metab Syndr | Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes. | 2016 | Details |
| A17955 | 27455806 | Nihon Rinsho | [Iron and liver disease]. | 2016 | Details |
| A17961 | 27449657 | Physiol Genomics | Early steatohepatitis in hyperlipidemic mice with endothelial-specific gain of TRPC3 function precedes changes in aortic atherosclerosis. | 2016 | Details |
| A17966 | 27446857 | Can J Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients. | 2016 | Details |
| A17979 | 27439352 | Singapore Med J | Managing non-alcoholic fatty liver disease. | 2016 | Details |
| A17996 | 27429213 | J Dig Dis | Advances in noninvasive methods for diagnosing nonalcoholic fatty liver disease. | 2016 | Details |
| A18004 | 27423696 | Am J Pathol | High-Fat Diet-Induced IL-17A Exacerbates Psoriasiform Dermatitis in a Mouse Model of Steatohepatitis. | 2016 | Details |
| A18007 | 27421788 | FASEB J | STK25 is a critical determinant in nonalcoholic steatohepatitis. | 2016 | Details |
| A18013 | 27415158 | Food Nutr Res | Lipolysis stimulating peptides of potato protein hydrolysate effectively suppresses high-fat-diet-induced hepatocyte apoptosis and fibrosis in aging rats. | 2016 | Details |
| A18025 | 27405478 | Surg Endosc | The effects of bariatric surgeries on nonalcoholic fatty liver disease. | 2016 | Details |
| A18038 | 27392972 | Obes Surg | Performance of the Bard Scoring System in Bariatric Surgery Patients with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A18041 | 27391242 | PLoS One | An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. | 2016 | Details |
| A18042 | 27389154 | Anatol J Cardiol | Non-alcoholic fatty liver disease-From the cardiologist perspective. | 2016 | Details |
| A18045 | 27386644 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Efficacy of Zaozhu Yinchen Recipe for Treating Non-alcoholic Steatohepatitis and its Effect on Free Fatty Acid and TNF-alpha]. | 2016 | Details |
| A18048 | 27384305 | Endocrinology | Male 11β-HSD1 Knockout Mice Fed Trans-Fats and Fructose Are Not Protected From Metabolic Syndrome or Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18056 | 27380600 | J Pediatr Gastroenterol Nutr | Pediatric NAFLD: the Future role of Patient-Tailored Probiotics Therapy. | 2016 | Details |
| A18061 | 27379445 | Inflamm Bowel Dis | Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease. | 2016 | Details |
| A18067 | 27373610 | Clin Liver Dis | The Pathology of Alcoholic Liver Disease. | 2016 | Details |
| A18068 | 27373160 | Cell Rep | Activation of CDK4 Triggers Development of Non-alcoholic Fatty Liver Disease. | 2016 | Details |
| A18075 | 27364348 | J Gastroenterol | Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model. | 2016 | Details |
| A18077 | 27363523 | Sci Rep | Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A18082 | 27358174 | Hepatology | Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives. | 2016 | Details |
| A18084 | 27356823 | Am J Gastroenterol | Editorial: Magnetic Resonance Elastography and Non-Alcoholic Fatty Liver Disease: Time for an Upgrade? | 2016 | Details |
| A18085 | 30695468 | Rinsho Byori | [Progress in the Management of NAFLD/NASH]. | 2016 | Details |
| A18088 | 29201749 | Euroasian J Hepatogastroenterol | Nonalcoholic Fatty Liver Disease in South Asia. | 2016 | Details |
| A18090 | 27355753 | Hepatol Res | Case report of diet-related improvements of non-alcoholic steatohepatitis evaluated by four consecutive liver biopsies. | 2016 | Details |
| A18099 | 27351871 | J Gastroenterol | The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease. | 2016 | Details |
| A18101 | 27351583 | Hepatol Res | Hepatic fat quantification using the two-point Dixon method and fat color maps based on non-alcoholic fatty liver disease activity score. | 2016 | Details |
| A18104 | 27349927 | Sci Rep | CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18109 | 27347998 | Nutrients | Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis. | 2016 | Details |
| A18110 | 27347680 | PLoS One | Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis. | 2016 | Details |
| A18114 | 27345301 | Cell Tissue Res | Reactive oxygen species and fibrosis: further evidence of a significant liaison. | 2016 | Details |
| A18118 | 27343380 | Eur J Pharmacol | (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation. | 2016 | Details |
| A18119 | 27342733 | Gene Expr | Enhanced Steatosis and Fibrosis in Liver of Adult Offspring Exposed to Maternal High-Fat Diet. | 2016 | Details |
| A18120 | 27342212 | Gastroenterology | Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol. | 2016 | Details |
| A18122 | 27341207 | PLoS One | The Association between Non-Invasive Hepatic Fibrosis Markers and Cardiometabolic Risk Factors in the Framingham Heart Study. | 2016 | Details |
| A18125 | 27339817 | Hepatology | Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. | 2016 | Details |
| A18129 | 27338123 | Hepatology | Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2016 | Details |
| A18130 | 27334577 | Diabet Med | Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China. | 2016 | Details |
| A18131 | 27333187 | PLoS One | Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice. | 2016 | Details |
| A18136 | 27326314 | World J Hepatol | Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy. | 2016 | Details |
| A18138 | 27324703 | J Diabetes Complications | Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome. | 2016 | Details |
| A18140 | 27323886 | Sci Rep | Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis. | 2016 | Details |
| A18144 | 27322798 | Ann Intern Med | Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial. | 2016 | Details |
| A18146 | 27321932 | Biochim Biophys Acta | Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice. | 2016 | Details |
| A18147 | 27321734 | J Agric Food Chem | Effects of Nonalcoholic Fatty Liver Disease on Hepatic CYP2B1 and in Vivo Bupropion Disposition in Rats Fed a High-Fat or Methionine/Choline-Deficient Diet. | 2016 | Details |
| A18150 | 27320964 | Toxicol Lett | MicroRNA-21 is associated with fibrosis in a rat model of nonalcoholic steatohepatitis and serves as a plasma biomarker for fibrotic liver disease. | 2016 | Details |
| A18159 | 27313636 | Hepat Mon | The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18160 | 27312339 | Sci Rep | Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes. | 2016 | Details |
| A18165 | 27311064 | Clin Transl Gastroenterol | Short-Term Hypocaloric High-Fiber and High-Protein Diet Improves Hepatic Steatosis Assessed by Controlled Attenuation Parameter. | 2016 | Details |
| A18168 | 27310371 | PLoS One | Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway. | 2016 | Details |
| A18173 | 27308959 | Scand J Gastroenterol | Feasibility of liver stiffness measurement in morbidly obese patients undergoing bariatric surgery using XL probe. | 2016 | Details |
| A18175 | 27308649 | J Gastrointestin Liver Dis | Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified Gastroenterologists. | 2016 | Details |
| A18177 | 27308647 | J Gastrointestin Liver Dis | Liver Stiffness Evaluation by Transient Elastography in Type 2 Diabetes Mellitus Patients with Ultrasound-proven Steatosis. | 2016 | Details |
| A18180 | 27307790 | Fibrogenesis Tissue Repair | Activation of hepatic stellate cell in Pten null liver injury model. | 2016 | Details |
| A18182 | 27306319 | Int J Toxicol | Intravenous Administration of Multiwalled Carbon Nanotubes Aggravates High-Fat Diet-Induced Nonalcoholic Steatohepatitis in Sprague Dawley Rats. | 2016 | Details |
| A18188 | 27301803 | Metabolism | Pharmacological management of nonalcoholic fatty liver disease. | 2016 | Details |
| A18190 | 27299860 | PLoS One | PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia. | 2016 | Details |
| A18193 | 27296438 | BMC Gastroenterol | Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine. | 2016 | Details |
| A18199 | 27289203 | Chemosphere | Fatty liver disease induced by perfluorooctane sulfonate: Novel insight from transcriptome analysis. | 2016 | Details |
| A18200 | 27288988 | Hepatol Res | Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection. | 2016 | Details |
| A18205 | 27287838 | Orv Hetil | [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016]. | 2016 | Details |
| A18209 | 27284700 | PLoS One | Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18211 | 27283259 | Gastroenterology | Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis. | 2016 | Details |
| A18214 | 27280634 | Br J Cancer | The impact of hepatic fibrosis on the incidence of liver metastasis from colorectal cancer. | 2016 | Details |
| A18215 | 27279429 | Aliment Pharmacol Ther | Magnetic resonance elastography identifies fibrosis in adults with alpha-1 antitrypsin deficiency liver disease: a prospective study. | 2016 | Details |
| A18216 | 27279075 | Sci Rep | Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease. | 2016 | Details |
| A18219 | 27277679 | Cell Death Dis | DJ-1 deficiency attenuates expansion of liver progenitor cells through modulating the inflammatory and fibrogenic niches. | 2016 | Details |
| A18223 | 27276398 | Clinics (Sao Paulo) | Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey. | 2016 | Details |
| A18224 | 27275239 | Open Access Maced J Med Sci | Combined Adiponectin Deficiency and Resistance in Obese Patients: Can It Solve Part of the Puzzle in Nonalcoholic Steatohepatitis. | 2015 | Details |
| A18225 | 27275102 | World J Gastroenterol | Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease. | 2016 | Details |
| A18227 | 27273168 | Nat Rev Gastroenterol Hepatol | The role of the gut microbiota in NAFLD. | 2016 | Details |
| A18231 | 27270473 | J Clin Endocrinol Metab | Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study. | 2016 | Details |
| A18246 | 27265388 | Aliment Pharmacol Ther | Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis. | 2016 | Details |
| A18253 | 27262842 | Acta Biochim Pol | Hepatokines and non-alcoholic fatty liver disease. | 2016 | Details |
| A18258 | 27261415 | J Hepatol | A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. | 2016 | Details |
| A18261 | 27258259 | Int J Mol Sci | Role of Hedgehog Signaling Pathway in NASH. | 2016 | Details |
| A18267 | 27254774 | Liver Int | ADAMTS5 deficiency protects against non-alcoholic steatohepatitis in obesity. | 2016 | Details |
| A18273 | 27249983 | Am J Gastroenterol | Editorial: A New Spin on Magnetic Resonance Elastography. | 2016 | Details |
| A18276 | 27248435 | Curr Protoc Mouse Biol | Development of a Representative Mouse Model with Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18277 | 27248434 | Curr Protoc Mouse Biol | An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present. | 2016 | Details |
| A18278 | 27247565 | Gastroenterol Res Pract | The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background. | 2016 | Details |
| A18281 | 27245430 | J Hepatol | Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis. | 2016 | Details |
| A18284 | 31239898 | Acad Forensic Pathol | Liver Pathology in First Presentation Diabetic Ketoacidosis at Autopsy. | 2016 | Details |
| A18292 | 27237577 | Metabolism | Non-alcoholic fatty liver disease and dyslipidemia: An update. | 2016 | Details |
| A18297 | 27233293 | J Pharmacol Exp Ther | Biliary Elimination of Pemetrexed Is Dependent on Mrp2 in Rats: Potential Mechanism of Variable Response in Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18298 | 27231906 | Int J Mol Sci | NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. | 2016 | Details |
| A18301 | 27227687 | Eur J Gastroenterol Hepatol | Adaptation of liver stiffness measurement depth in bariatric surgery candidates with suspected nonalcoholic fatty liver disease. | 2016 | Details |